Literature DB >> 29627015

Spinal cord infarction: Clinical and imaging insights from the periprocedural setting.

Nicholas L Zalewski1, Alejandro A Rabinstein2, Karl N Krecke3, Robert D Brown2, Eelco F M Wijdicks2, Brian G Weinshenker2, Derrick A Doolittle3, Eoin P Flanagan4.   

Abstract

OBJECTIVE: Describe the range of procedures associated with spinal cord infarction (SCI) as a complication of a medical/surgical procedure and define clinical and imaging characteristics that could be applied to help diagnose spontaneous SCI, where the diagnosis is often less secure.
METHODS: We used an institution-based search tool to identify patients evaluated at Mayo Clinic, Rochester, MN from 1997 to 2016 with a periprocedural SCI. We performed a descriptive analysis of clinical features, MRI and other laboratory findings, and outcome.
RESULTS: Seventy-five patients were identified with SCI related to an invasive or non-invasive surgery including: aortic aneurysm repair (49%); other aortic surgery (15%); and a variety of other procedures (e.g., cardiac surgery, spinal decompression, epidural injection, angiography, nerve block, embolization, other vascular surgery, thoracic surgery) (36%). Deficits were severe (66% para/quadriplegia) and maximal at first post-procedural evaluation in 61 patients (81%). Impaired dorsal column function was common on initial examination. Imaging features included classic findings of owl eyes or anterior pencil sign on MRI (70%), but several other T2-hyperintensity patterns were also seen. Gadolinium enhancement of the SCI and/or cauda equina was also common when assessed. Six patients (10%) had an initial normal MRI despite a severe deficit.
CONCLUSIONS: Procedures associated with SCI are many, and this complication does not exclusively occur following aortic surgery. The clinical and radiologic findings that we describe with periprocedural SCI may be used in future studies to help distinguish spontaneous SCI from alternate causes of acute myelopathy.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ischemic myelopathy; Spinal cord infarction; Spinal cord stroke; Vascular myelopathy

Mesh:

Substances:

Year:  2018        PMID: 29627015     DOI: 10.1016/j.jns.2018.03.029

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria.

Authors:  Nicholas L Zalewski; Alejandro A Rabinstein; Karl N Krecke; Robert D Brown; Eelco F M Wijdicks; Brian G Weinshenker; Timothy J Kaufmann; Jonathan M Morris; Allen J Aksamit; J D Bartleson; Giuseppe Lanzino; Melissa M Blessing; Eoin P Flanagan
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

2.  Spinal Stroke following Kidney Transplant.

Authors:  Jayanthan B Subramanian; Farjad Siddiqui; Pranit N Chotai; Yazan Al-Adwan; Amer Rajab; Kenneth Washburn; Austin D Schenk; Ashley J Limkemann; Michael Luttrull; Musab Al-Ebrahim; Ginny Bumgardner; Navdeep Singh
Journal:  Case Rep Transplant       Date:  2022-05-21

3.  Spontaneous spinal cord infarction in Austria: a two-center comparative study.

Authors:  Slaven Pikija; Alexander B Kunz; Raffaele Nardone; Christian Enzinger; Johannes A R Pfaff; Eugen Trinka; Thomas Seifert-Held; Johann Sellner
Journal:  Ther Adv Neurol Disord       Date:  2022-03-11       Impact factor: 6.570

4.  Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions.

Authors:  Rafid Mustafa; Theodore J Passe; Alfonso S Lopez-Chiriboga; Brian G Weinshenker; Karl N Krecke; Nicholas L Zalewski; Felix E Diehn; Elia Sechi; Jay Mandrekar; Timothy J Kaufmann; Padraig P Morris; Sean J Pittock; Michel Toledano; Giuseppe Lanzino; Allen J Aksamit; Neeraj Kumar; Claudia F Lucchinetti; Eoin P Flanagan
Journal:  Neurol Clin Pract       Date:  2021-10

5.  Features of non-traumatic spinal cord infarction on MRI: Changes over time.

Authors:  Bo Ra Kim; Kyung Seok Park; Hyo Jin Kim; Jun Yup Kim; Bo Ram Kim; Eugene Lee; Joon Woo Lee
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.